Sarcoid- like Phenomenon - ustekinumab induced granulomatous
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Monoclonal antibody therapies have been frequently used in recent years in the treatment of chronic inflammatory disorders due to their distinctive immunosuppressive and selective properties. Ustekinumab is a human monoclonal antibody (mAb) designed to block interleukin (IL)-12 and IL-23 from binding to their p40 Beta subunit receptors on the surface of T and natural killer (NK) cells.

A 50-year-old Causcasian man with a known history of refractory psoriasis on treatment with ustekinumab presented with a complaint of significant weight loss and shortness of breath. Physical examination was unremarkable and blood cultures were negative. A chest computed tomography (CT) scan was performed and revealed a large right lung mass with adjacent nodularity in addition to right-sided pleural effusion, and possibility of primary lung malignancy was raised.

Therapeutic thoracocentesis was done; fluid cytology and analysis were negative for malignancy, acid-fast bacilli, or fungal infections.

Source: Journal of Medical Case Reports

Read more: https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-019-2137-1
Like
Comment
Share